Davis's Drug Guide
NPH insulin (isophane insulin suspension)
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Trade Name(s)
- HumuLIN N
- HumuLIN N KwikPen
- NovoLIN N
- NovoLIN N FlexPen
Ther. Class.
Pharm. Class.
pancreatics
See insulins and insulin therapy for more information concerning insulins
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "NPH Insulin (isophane Insulin Suspension)." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2024. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/109057/all/NPH_insulin__isophane_insulin_suspension_.
Vallerand AHA, Sanoski CAC, Quiring CC. NPH insulin (isophane insulin suspension). Davis's Drug Guide. F.A. Davis Company; 2024. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/109057/all/NPH_insulin__isophane_insulin_suspension_. Accessed December 18, 2024.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2024). NPH insulin (isophane insulin suspension). In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/109057/all/NPH_insulin__isophane_insulin_suspension_
Vallerand AHA, Sanoski CAC, Quiring CC. NPH Insulin (isophane Insulin Suspension) [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2024. [cited 2024 December 18]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/109057/all/NPH_insulin__isophane_insulin_suspension_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - NPH insulin (isophane insulin suspension)
ID - 109057
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/109057/all/NPH_insulin__isophane_insulin_suspension_
PB - F.A. Davis Company
ET - 19
DB - Medicine Central
DP - Unbound Medicine
ER -
